Legal

Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC

SAMR prohibits monopoly agreements that fix or modify pharmaceutical prices.

New rules applicable to Shanghai's Lin-Gang New Area have been released. Wenpei Yu and Yunsi Hu of Lifeng Partners analyze their workings, how they fit into China's existing system of cross-border data transfer rules and why they are so significant for biomedical companies operating in the zone

Nasdaq questioned the identities and backgrounds of Chinese IPO investors; China rolls out new phase of Golden Tax System; and U.S. Congress attempts to prevent Chinese companies from using de minimis loophole to avoid tariffs

SAMR prohibits monopoly agreements that fix or modify pharmaceutical prices. Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC. Guidelines are provided for the methods of monitoring data interface security risks.

PBOC specifies minimum registered capital requirements of non-bank payment institutions

A QFII may select at its own discretion the currency it remits inwards to invest in domestic securities or futures

U.S. plans to restrict Chinese software in electric and internet-connected cars; China increases control over offshore capital flows; and Chinese firms plan to expand into the U.S. Midwest but have regulatory concerns.

Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.